PTJ
NEO icon

Paul Tudor Jones’s NeoGenomics NEO Stock Holding History

Paul Tudor Jones’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Sell
24,000
-12,000
-33% -$116K ﹤0.01% 3036
2026
Q1 		$267K Buy
36,000
+10,000
+38% +$105K ﹤0.01% 3214
2025
Q4 		$306K Buy
+26,000
New +$281K ﹤0.01% 3039

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Paul Tudor Jones's NEO Position: Q2 2026 in Review

Paul Tudor Jones sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 17,820 shares — an estimated $172K sold.

Paul Tudor Jones first reported a position in NEO in Q2 2016 and held it in 23 quarters. The position peaked at $5.09M in Q2 2025. 265 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Paul Tudor Jones reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 17,820 NeoGenomics shares in Q2 2026, an estimated $172K.
  • Paul Tudor Jones first reported a position in NeoGenomics in Q2 2016 and held it in 23 quarters.
  • Paul Tudor Jones's NeoGenomics position peaked at $5.09M in Q2 2025.
  • 265 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.